SCHEMBL4897729

SCHEMBL4897729

CNS(=O)(=O)c1ccc(CN(C)c2c(Nc3ccc4[nH]cnc4c3)c(=O)c2=O)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNNI3K Q59H18 9/20 0.33
BRAF P15056 3/20 0.33
IP6K1 Q92551 1/20 0.33
HTR7 P34969 1/20 0.33
HTR5A P47898 1/20 0.33
HTR6 P50406 1/20 0.33
QPCT Q16769 2/20 0.33
TAS2R14 Q9NYV8 1/20 0.32
THRB P10828 1/20 0.32
CCNB2 O95067 1/20 0.32
CDK1 P06493 1/20 0.32
CCNB1 P14635 1/20 0.32
CCNA2 P20248 1/20 0.32
CDK2 P24941 1/20 0.32
CCNA1 P78396 1/20 0.32
CCNB3 Q8WWL7 1/20 0.32
ALOX5AP P20292 1/20 0.32
FEN1 P39748 1/20 0.32
PIK3CA P42336 1/20 0.31
KDR P35968 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4908463 0.83 ROCK1 (0.45) TNNI3KBRAFIP6K1QPCTTAS2R14
SCHEMBL4905239 0.80 HSD17B1 (0.36) IP6K1QPCTCDK1CDK2KDR
SCHEMBL4897232 0.75 ROCK2 (0.44) TNNI3KBRAFCDK1CDK2KDR
SCHEMBL4905370 0.73 ROCK1 (0.46) IP6K1QPCTCDK1CDK2KDR
SCHEMBL31647242 0.71 TAS2R14 (0.51) TNNI3KBRAFHTR7HTR5AHTR6
SCHEMBL4897323 0.71 GSK3B (0.48) CDK1CCNB1CDK2
SCHEMBL4900176 0.70 ALOX5AP (0.40) TNNI3KBRAFIP6K1QPCTCDK1
SCHEMBL4904962 0.69 GSK3B (0.47) IP6K1QPCTCDK1CDK2KDR
SCHEMBL4910893 0.69 ROCK1 (0.47) IP6K1QPCTCDK1CDK2KDR
SCHEMBL4908343 0.69 ROCK1 (0.46) IP6K1CDK1CDK2KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080234266-A1 Squaric Acid Derivatives II MERCK PATENT GESELLSCHAFT (DE) 2008-09-25 US claimed
US-20080234266-A1 Squaric Acid Derivatives II MERCK PATENT GESELLSCHAFT (DE) 2008-09-25 US disclosed
US-20080234266-A1 Squaric Acid Derivatives II MERCK PATENT GESELLSCHAFT (DE) 2008-09-25 US disclosed
WO-2007014608-A1 QUADRATIC ACID II DERIVATIVES MERCK PATENT GMBH (DE) 2007-02-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080234266-A1 Squaric Acid Derivatives II CHEK2, CHEK1, SGK3 TNNI3K 168/4885BRAF 758/4885IP6K1 121/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.